Osteomyelitis: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
| − | * |
+ | *See also: |
| − | ** |
+ | **[[Acute osteomyelitis]] |
| − | ** |
+ | **[[Chronic osteomyelitis]] |
| − | == |
+ | ==Management== |
| − | * |
+ | *No clinically meaningful differences in bone penetration between classes of antibiotics exist[[CiteRef::landersdorfer2009pe]] |
| − | * |
+ | *Bioavailability likely still important |
[[Category:Bone and joint infections]] |
[[Category:Bone and joint infections]] |
||
Revision as of 14:44, 18 September 2020
- See also:
Management
- No clinically meaningful differences in bone penetration between classes of antibiotics exist1
- Bioavailability likely still important
References
- ^ Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
